Research programme: interleukin-1 receptor-associated kinase-4 inhibitors - AurigeneAlternative Names: IRAK4 inhibitors - Aurigene
Latest Information Update: 15 Jul 2014
At a glance
- Originator Aurigene Discovery Technologies
- Class Small molecules
- Mechanism of Action Interleukin-1 receptor-associated kinase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cancer
Most Recent Events
- 24 Jun 2014 Preclinical trials in Cancer in India (unspecified route)